Clinical, Microbiological and Biochemical Effects of the Antimicrobial Photodynamic Therapy
NCT ID: NCT01532674
Last Updated: 2012-02-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
40 participants
INTERVENTIONAL
2011-11-30
2013-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Periodontal Debridement Associated With Systemic Antibiotics and Single/Repeated PDT to Treat Aggressive Periodontitis
NCT03132714
Antimicrobial Photodynamic Therapy in Patients With Periodontal Disease and Type 2 Diabetes Mellitus
NCT05816941
Photodynamic in Periodontal Treatment
NCT05162417
Photodynamic Therapy in Non-surgical Periodontal Therapy
NCT07080762
Nonsurgical Periodontal Treatment Associated or Not With Systemic Antibiotics and Photodynamic Therapy
NCT03142776
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Antimicrobial photodynamic therapy
Antimicrobial photodynamic therapy and scaling and root planing
Antimicrobial photodynamic therapy (Periowave) and scaling and root planing
ROOT PLANNING PROCEDURE:
The procedure is the same as in the control group
APPLICATION PROCEDURES OF THE PHOTOSENSITIZING AGENT :
The photosensitive agent : Formulation Periowave Treatment Kit-2ml
* Application of the photosensitive using a blunt needle at the bottom of the periodontal pocket with circular movements covering the entire perimeter of the tooth.
* Application of diode laser with a peak of 8.5 cm. long with a curvature of 60 degrees and flexible. Making a move in and out from the apical region to the more coronal region of the periodontal pocket. Each tooth has a working time of 60 seconds.
* All the periodontal pockets will be treated subgingivally
* Elimination of the photosensitive by irrigation
scaling and root planing
Only scaling and root planing
scaling and root planing
ROOT PLANNING PROCEDURE:
An unique operator ( independent from the explorer) will do the root planing for both the test and control group.
Every procedure will be done under local anaesthesia: Ultracain with Epinephrine 40/0,01 mg/ml. NORMON. It will be done a first session of root planning in the first and forth quadrant and in a 48 hours the root planning of the second and the third quadrant will be done. Every session wil be done with this material: Ultrasonic: Satelec suprasson p5 with ultrasonic tip H3, manual scalers: HU-FRIEDY 1/2, 7/8, 11/12, 13/14, 13/14 columbia.
\* The session will finish as soon as the operator have removed all the supragingival and subgingival calculus and plaque.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Antimicrobial photodynamic therapy (Periowave) and scaling and root planing
ROOT PLANNING PROCEDURE:
The procedure is the same as in the control group
APPLICATION PROCEDURES OF THE PHOTOSENSITIZING AGENT :
The photosensitive agent : Formulation Periowave Treatment Kit-2ml
* Application of the photosensitive using a blunt needle at the bottom of the periodontal pocket with circular movements covering the entire perimeter of the tooth.
* Application of diode laser with a peak of 8.5 cm. long with a curvature of 60 degrees and flexible. Making a move in and out from the apical region to the more coronal region of the periodontal pocket. Each tooth has a working time of 60 seconds.
* All the periodontal pockets will be treated subgingivally
* Elimination of the photosensitive by irrigation
scaling and root planing
ROOT PLANNING PROCEDURE:
An unique operator ( independent from the explorer) will do the root planing for both the test and control group.
Every procedure will be done under local anaesthesia: Ultracain with Epinephrine 40/0,01 mg/ml. NORMON. It will be done a first session of root planning in the first and forth quadrant and in a 48 hours the root planning of the second and the third quadrant will be done. Every session wil be done with this material: Ultrasonic: Satelec suprasson p5 with ultrasonic tip H3, manual scalers: HU-FRIEDY 1/2, 7/8, 11/12, 13/14, 13/14 columbia.
\* The session will finish as soon as the operator have removed all the supragingival and subgingival calculus and plaque.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. The subject is diagnosed with moderate or advanced chronic periodontitis.
3. The subject has at least 4 sites with PD of ≥5 mm + bleeding in at least two quadrants of the mouth.
4. A signed Informed Consent will be obtained.
5. The subject is an adult male or female \> 18 years of age.
6. The subject has \>18 fully erupted teeth, at least 3 teeth in each quadrant with one or more posterior teeth per quadrant (3º molars excluded).
7. The subject is willing and able to return for treatment and evaluation procedures scheduled throughout the course of this clinical study.
Exclusion Criteria
2. The subject is a current smoker.
3. The subject has an active malignancy of any type by subject report.
4. The subject has chronic disease or diminished mental capacity that would mitigate the ability to comply with the protocol.
5. The subject has any significant chronic disease (either acute or chronic) or who is taking a medication with concomitant oral manifestations that in the opinion of the investigator would interfere with evaluation of safety or efficacy of the study.
6. The subject has an active periapical abscess or periodontal abscess or a history of acute necrotizing ulcerative gingivitis.
7. The subject has been treated with antibiotics within the 3-month period prior to beginning the study or any systemic condition which requires antibiotic coverage for routine periodontal procedures (e.g. heart conditions, joint replacements, etc.) by report of the subject.
8. The subject has a known allergy to Methylene Blue, polimetil metacrilate or chlorhexidine.
9. The subject Has severe glucose-6-phosphate dehydrogenase (G6PD) deficiency by subject report.
10. The subject currently uses anti-coagulant therapy at therapeutic doses.
11. The subject is currently using any photosensitizing medications.
12. Patients who have received SRP or Periodontal supportive therapy in the last 6 months
13. It is considered \> 30% of plaque of an index of 2 or more in the Silness y Löe plaque index the patient in the study.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ondine Research Laboratories
INDUSTRY
Spanish Society of Periodontology and Osseointegration ( SEPA)
UNKNOWN
Francisco Alpiste Illueca
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Francisco Alpiste Illueca
University Professor of University of Valencia
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alpiste Illueca Francisco, Professor
Role: PRINCIPAL_INVESTIGATOR
University of Valencia
Segarra vidal marta, postgraduate
Role: STUDY_DIRECTOR
University of Valencia
López Roldán Andrés, Professor
Role: STUDY_CHAIR
University of Valencia
Puchades Rufino Juan, professor
Role: STUDY_CHAIR
University of Valencia
gil loscos francisco, professor
Role: STUDY_CHAIR
University of Valencia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Valencia
Valencia, Valencia, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UV1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.